Recap: Karyopharm Therapeutics Q4 Earnings

Karyopharm Therapeutics KPTI reported its Q4 earnings results on Tuesday, February 8, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Karyopharm Therapeutics beat estimated earnings by 193.88%, reporting an EPS of $0.46.

Revenue was up $91.17 million from the same period last year.

Last quarter the company missed on EPS by $0.02, which was followed by a 0.38% increase in the share price the next day.

Here's a look at Karyopharm Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.67	-0.74	-0.71	-0.59
EPS Actual	-0.69	-0.71	-0.77	-0.59
Revenue Estimate	25.80M	25.64M	25.17M	29.37M
Revenue Actual	37.69M	22.60M	23.26M	35.10M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar